Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems
- PMID: 1423302
Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems
Abstract
Since human colorectal tumors are insensitive to most chemotherapeutic agents, there is a need for the discovery of new drugs that would show activity against this disease. In an attempt to better appreciate the relevance of a widely used mouse colon tumor (colon adenocarcinoma Co38) as a screening model for human colorectal tumors, we compared the main phase I and phase II drug-metabolizing enzyme systems in both tumoral and nontumoral colon tissues. The following enzymes were assayed by Western blot: cytochromes P-450 (1A1/A2, 2B1/B2, 2C, 2E1, and 3A), epoxide hydrolase, and glutathione-S-transferases (GST-alpha, -mu, and -pi). The activities of the following enzymes or cofactors were determined by spectrophotometric or fluorometric assays: total cytochrome P-450, 1-chloro-2,4-dinitrobenzene-GST, selenium-independent glutathione peroxidase, 3,4-dichloronitrobenzene-GST, ethacrynic acid-GST, total glutathione, epoxide hydrolase, UDP-glucuronosyltransferase, beta-glucuronidase, sulfotransferase, and sulfatase. Results obtained by Western blot showed that mouse colon adenocarcinoma Co38 did not express any of the probed cytochromes P-450, whereas human colorectal tumors expressed only low levels of cytochrome P-450 3A. GST-alpha and GST-pi were detected in all tumoral and nontumoral tissues of both species. The neutral GST-mu was expressed in all murine tissues investigated and was found to be polymorphic in human tissues. For human peritumoral and tumoral colorectal tissues there was no significant difference between GST isoenzyme levels, whereas mouse colon adenocarcinoma Co38 had a lower expression of GST-mu and GST-pi, compared to normal mouse colon. Enzymatic activities for glutathione peroxidase, 3,4-dichloronitrobenzene-GST, and ethacrynic acid-GST confirmed the Western blot results for GST-alpha, GST-mu, and GST-pi, respectively. Total GSH levels were similar between murine and human tumors but were 3-fold higher in human tumors than in peritumoral tissues, whereas they were 7-fold lower in mouse colon tumor Co38, compared to normal mouse colon. Epoxide hydrolase was not expressed in either mouse colon adenocarcinoma Co38 or normal mouse colon tissues, whereas it was expressed in human colon peritumoral and tumoral tissues at similar levels. No significant difference was observed between human tumors and peritumoral tissues for UDP-glucuronosyltransferase, beta-glucuronidase, sulfotransferase, and sulfatase. For murine colon tissues, the conjugation pathways (UDP-glucuronosyltransferase and sulfotransferase) were lower in colon adenocarcinoma Co38, whereas the converse was observed for the corresponding hydrolytic enzymes (beta-glucuronidase and sulfatase).(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
[Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors].Bull Cancer. 1993 May;80(5):397-407. Bull Cancer. 1993. PMID: 8173193 French.
-
Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.Cancer Res. 1993 Aug 1;53(15):3541-6. Cancer Res. 1993. PMID: 8339260
-
Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.Cancer Res. 1993 Oct 1;53(19):4608-12. Cancer Res. 1993. PMID: 8402635
-
Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.Drug Metab Rev. 2015 May;47(2):199-221. doi: 10.3109/03602532.2014.996649. Epub 2015 Feb 17. Drug Metab Rev. 2015. PMID: 25686853 Review.
-
Glutathione S-transferases--biomarkers of cancer risk and chemopreventive response.Chem Biol Interact. 1998 Apr 24;111-112:377-88. doi: 10.1016/s0009-2797(97)00174-9. Chem Biol Interact. 1998. PMID: 9679568 Review.
Cited by
-
Human cell lines as models for multidrug resistance in solid tumours.Cytotechnology. 1993;12(1-3):231-56. doi: 10.1007/BF00744666. Cytotechnology. 1993. PMID: 7765327 Review.
-
Elevated levels of the pro-carcinogenic adduct, O(6)-methylguanine, in normal DNA from the cancer prone regions of the large bowel.Gut. 2000 Sep;47(3):362-5. doi: 10.1136/gut.47.3.362. Gut. 2000. PMID: 10940272 Free PMC article.
-
Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.Cancer Chemother Pharmacol. 2011 Aug;68(2):445-55. doi: 10.1007/s00280-010-1505-8. Epub 2010 Nov 11. Cancer Chemother Pharmacol. 2011. PMID: 21069336 Free PMC article.
-
Zinc oxide nanosphere for hydrogen sulfide scavenging and ferroptosis of colorectal cancer.J Nanobiotechnology. 2021 Nov 27;19(1):392. doi: 10.1186/s12951-021-01069-y. J Nanobiotechnology. 2021. PMID: 34838036 Free PMC article.
-
Human colonocyte detoxification.Gut. 1997 Dec;41(6):731-4. doi: 10.1136/gut.41.6.731. Gut. 1997. PMID: 9462203 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous